GAMMA Investing LLC Raises Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

GAMMA Investing LLC grew its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 4,530.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,225 shares of the company’s stock after buying an additional 36,421 shares during the quarter. GAMMA Investing LLC’s holdings in Pediatrix Medical Group were worth $539,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in MD. Nomura Asset Management Co. Ltd. raised its position in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after acquiring an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust raised its position in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after acquiring an additional 1,040 shares in the last quarter. AlphaQuest LLC raised its position in shares of Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after acquiring an additional 2,012 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock worth $91,000 after acquiring an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its position in shares of Pediatrix Medical Group by 218.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company’s stock worth $98,000 after acquiring an additional 5,104 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Down 0.3%

Shares of MD stock opened at $13.37 on Thursday. The stock’s 50-day simple moving average is $13.67 and its 200-day simple moving average is $13.97. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.81 and a current ratio of 1.81. The firm has a market capitalization of $1.15 billion, a PE ratio of -13.23, a P/E/G ratio of 0.93 and a beta of 1.27. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The company’s revenue was down 7.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.20 earnings per share. Equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on MD. Truist Financial reduced their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. Macquarie upped their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research report on Thursday, May 8th. Finally, UBS Group reduced their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a research report on Monday, May 12th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $16.67.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.